TScan Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
TScan Therapeutics Inc
TickerTCRX
CIK #0001783328
CUSIP89854M101
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address830 Winter Street, Waltham, MA 02451
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
TScan Therapeutics Inc 2021-01-28 100.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001783328] 10-K
[0001783328] 10-Q
[0001783328] 3
[0001783328] 4
[0001783328] 8-K
[0001783328] D
[0001783328] SC 13D
[0001783328] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc TScan Therapeutics Inc [2024-11-08] 9.5
BlackRock Inc TScan Therapeutics Inc [2024-10-21] 9.5
Cormorant Asset Management LP TScan Therapeutics Inc [2024-04-29] 5.15
Adage Capital Partners GP LLC TScan Therapeutics Inc [2023-06-12] 0.35
Biotechnology Value Fund L P TScan Therapeutics Inc [2023-06-05] 6.8
EcoR1 Capital LLC TScan Therapeutics Inc [2023-06-05] 11.7
Lynx1 Capital Management LP TScan Therapeutics Inc [2023-06-02] 12.2
K2 Healthventures Equity Trust LLC TScan Therapeutics Inc [2022-09-30] 0.985
Deer IX & Co Ltd TScan Therapeutics Inc [2022-02-14] 3.7
Hillhouse Investment Management Ltd TScan Therapeutics Inc [2022-02-14] 6.9
Pitango Healthtech Fund I LP TScan Therapeutics Inc [2022-02-14] 4.4
GV 2017 LP TScan Therapeutics Inc [2022-02-14] 3.45
Longwood Fund IV LP TScan Therapeutics Inc [2022-02-10] 6.9
BlackRock Inc TScan Therapeutics Inc [2022-02-04] 8.0
RA Capital Management LP TScan Therapeutics Inc [2021-07-28] 6.7
Baker Bros Advisors LP TScan Therapeutics Inc [2021-07-22] 7.6
Form 3/4/5 Filer 2011 - 2026
Klencke Barbara
TScan Therapeutics Inc
Nicholson Garry A
Gruia Gabriela
Dorton Katina
Woods Keith
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
Baker Felix
Baker Bros Advisors LP
Zdraveski Zoran
Louis Chrystal
Amello Jason
MacBeath Gavin
Dworak Leiden
Nichols Weston
Lynx1 Capital Management LP
Barberich Timothy J
Silver Brian M
Barton Debora
EcoR1 Capital LLC
Southwell David P
Desmarais William
Harel Ittai
Westphal Christoph H
Biggar Stephen R
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Amello Jason
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 350,000 $0.00
MacBeath Gavin
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 1,165,000 $0.00
Dworak Leiden
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 100,000 $0.00
Louis Chrystal
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 420,000 $0.00
Zdraveski Zoran
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 350,000 $0.00
Nichols Weston +1
Common Stock
2025-12-23 Buy 6,232 $0.90 5,609
Nichols Weston +1
Common Stock
2025-12-22 Buy 75,500 $0.90 67,950
Nichols Weston +1
"Common stock, $0.0001 par value per share (""Common Stock"")"
2025-12-19 Buy 80,069 $0.90 72,062
Baker Brothers Life Sciences LP +5
Non- Qualified Stock Option (right to buy) · derivative
2025-06-30 Grant 67,000 $0.00
Baker Brothers Life Sciences LP +5
Non- Qualified Stock Option (right to buy) · derivative
2025-06-30 Grant 67,000 $0.00
Klencke Barbara
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
Nicholson Garry A
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
Woods Keith
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
Dorton Katina
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
Gruia Gabriela
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
Nichols Weston +1
Common Stock
2025-05-20 Buy 1,200,000 $1.20 1,440,000
Nichols Weston +1
"Common stock, $0.0001 par value per share (""Common Stock"")"
2025-05-19 Buy 1,388,794 $1.20 1,666,553
Amello Jason
Stock Option (Right to Buy) · derivative
2025-01-03 Grant 270,000 $0.00
Zdraveski Zoran
Stock Option (Right to Buy) · derivative
2025-01-03 Grant 250,000 $0.00
MacBeath Gavin
Stock Option (Right to Buy) · derivative
2025-01-03 Grant 800,000 $0.00
showing 20 of 135 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 60 32,503,948
2025-12-31 61 30,718,552
2025-09-30 73 34,941,091
2025-06-30 81 35,712,032
2025-03-31 93 40,135,892
2024-12-31 91 41,522,870
2024-09-30 90 41,867,329
2024-06-30 81 41,467,503
2024-03-31 67 34,773,103
2023-12-31 55 32,180,822
2023-09-30 33 28,588,231
2023-06-30 29 27,951,619
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com